Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014

Pain Therapeutics

19 May 2014 - 20 May 2014 - London, UK

Bookmark and Share

Assess Alternative Approaches to Animal Models to Minimise the Translational Gap and Accelerate Market Access

Pain Therapeutics 2014 will evaluate the latest regulatory guidelines on pain indications and assess the pricing and reimbursement issues which are faced with generic incursion and patent expiration.

Hear an in-depth analysis of new pain therapeutic targets from bench to bedside and assess the pipeline of novel drugs for unique insights into developments that could restore positive growth in the market.


  • Discuss and evaluate the latest new therapeutic mechanisms from bench to bedside with key insight from Merck, Spinifiex, Eli Lilly, AbbVie and UCB
  • Hear key presentations from Mundipharma, Nektar and on advances to opioids and strategies to reduce abuse potential
  • Explore the latest in the area of Neuropathic pain for 2014 with the latest case studies from Neuroscience Technologies and GW Pharmaceuticals
  • Evaluate the translation gap with case studies from a pre-clinical and clinical perspective from Karolinska Institutet and OGB Consulting


  • Jordi Serra, CSO, Neuroscience Technologies Ltd
  • Samer Eid, Neuroscience Scientific Knowledge, Merck & Co.
  • Tom McCarthy, Chief Executive Officer and Managing Director, Spinifex Pharmaceuticals
  • Kathleen Kelly, Medical Leader, CNS/Pain, Johnson & Johnson
  • Zara Sands, Computational Medicinal Chemist, UCB
  • Birgit Priest, Senior Scientist, Eli Lilly
  • Philip Kym, Associate Director II, Pain Discovery Research, Abbott Laboratories

Pain Therapeutics has been a premier conference in its field for more than a decade and the 14th instalment will bring together even more key industry experts and leading pioneers to discuss, debate and share ideas and challenges facing the pain management arena. 


Alternatively contact John Collins on +44 (0)20 7827 6734 or email 

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos